Metformina Bluefish

Metformin, the active ingredient in Metformina Bluefish, is a biguanide presented as an oral tablet for oral use. It treats type 2 diabetes mellitus in adults by improving blood glucose control. It belongs to the biguanide class and is administered orally, providing a convenient option for chronic management of hyperglycemia.

GNH USA supplies Metformina Bluefish as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product complies with EU pharmaceutical standards and is distributed to a broad network of healthcare providers.

Metformina Bluefish (metformin) is used in the management of disorders related to impaired glucose regulation.

- Type 2 diabetes mellitus (monotherapy): lowers fasting plasma glucose and HbA1c levels. - Type 2 diabetes mellitus (combination therapy): enhances glycemic control when added to other antidiabetic agents. - Type 2 diabetes mellitus (insulin resistance): improves peripheral insulin sensitivity to reduce glucose production.

Metformina Bluefish may be associated with a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Nausea: mild to moderate feeling of sickness. - Diarrhea: loose stools occurring especially after dose initiation. - Abdominal discomfort: cramping or pain in the stomach area. - Metallic taste: transient alteration in taste perception.

Serious or Rare Side Effects: - Lactic acidosis: a rare but life‑threatening buildup of lactate. - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatic dysfunction: significant elevation of liver enzymes or liver failure.

Before prescribing Metformina Bluefish, clinicians should consider several safety aspects to minimize risk. - Renal function: assess eGFR before initiating and periodically during therapy. - Hepatic function: evaluate liver enzymes to detect impairment. - Lactic acidosis risk: avoid in patients with hypoxia, severe infection, or uncontrolled heart failure. - Heart failure: use with caution in NYHA class III/IV conditions. - Vitamin B12: monitor levels during long‑term treatment as deficiency may develop. - Store at ambient temperature: keep in the original container, protect from moisture and heat.

Metformina Bluefish can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Iodinated contrast agents: increase risk of renal impairment and lactic acidosis. - Cimetidine: raises metformin plasma concentrations, heightening toxicity risk. - Alcohol: potentiates lactic acidosis, especially with chronic intake.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask symptoms of hypoglycemia. - Thiazide diuretics: can attenuate glucose‑lowering effect of metformin.